You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
See how Medtronic Targeted Drug Delivery helps you manage chronic pain.
Targeted drug delivery provides effective pain relief by delivering medication directly to the fluid surrounding the spinal cord via a programmable pump.1,2
A trial allows you to try targeted drug delivery before you commit to an implant.
During the surgery, the targeted drug delivery pump is implanted just under the skin of the abdomen.
At follow up appointments, your physician fills the pump with pain medication. The pump sends the medication through the catheter to the spinal area where pain receptors are located. You return to your physician’s office for more medicine when the pump needs to be refilled.
Surgical complications are possible. Some of these complications may include infection, headache, spinal fluid leak, or paralysis.
Do not have the implant surgery if you have an active infection at the time, or if your body size is too small to hold the drug pump.
Once the device is implanted, device complications or adverse drug events may occur, which could be life threatening or require additional surgery to resolve.
Please see Important Safety Information for more details. Always discuss the benefits and risks of this therapy with your physician.
Hamza M, Doleys D, Wells M, et al. Prospective study of 3-year follow-up of low dose intrathecal opioids in the management of chronic nonmalignant pain. Pain Med. 2012;13:1304-1313.
Deer T, Chapple I, Classen A, et al. lntrathecal drug delivery for treatment of chronic low back pain: report from the National Outcomes Registry for Low Back Pain. Pain Med. 2004;5:6-13.
Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain. 2001;5:353-361.
Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncot. 2002;20:4040-4049.
Smith TJ, Swainey C, Coyne PJ. Pain management, including intrathecal pumps. Curr Pain Headache Rep. 2005 Aug;9(4):243-8